First comprehensive DNA study of mast cell leukemia uncovers clues that could improve therapy

Cancer researchers have carried out the first comprehensive study of the changes seen in the DNA of a patient with mast cell leukemia, an extremely aggressive subtype of acute myeloid leukemia with a very poor prognosis. Their genomic survey has helped identify two previously unknown mutations that could directly influence patient response to currently available therapeutic drugs.

Read the whole article on Science Daily

More from Science Daily